What is a rare disease patient group?
Rare disease patient groups play a vital role in the rare disease ecosystem, acting as advocates, facilitators, and the driving force for advancements in care, research, and policy.
In this guide, you’ll learn what rare disease patient groups are and their importance, not only for patients and families, but also as key collaborators with multiple stakeholders, like healthcare professionals, academics, researchers, regulators, funders or policymakers.
You’ll learn about common challenges faced by patient groups and practical advice on how to start navigating them.
With thanks to the Funders of The Empowerment Programme 2024
Resource type
Course
Skill level
Beginner
Duration
1 hour
Last updated
November 2024
Resource type
Course
Skill level
Beginner
Duration
1 hour
Last updated
November 2024
What will you learn?
- What rare disease patient groups are, with examples
- The importance of patient groups in the rare disease community, providing support, education and advocacy
- The importance of collaboration to increase impact
- Successful examples of patient group collaborations to educate professionals, influence research priorities, develop treatments and shape healthcare policies
- The main challenges faced by patient groups and initial advice to navigate them
- How patient groups can drive change by collaborating with multiple stakeholders, including healthcare professionals, researchers and pharmaceutical companies
Who is this course for?
This course is designed for anyone seeking to learn more about the role and importance of rare disease patient groups in the wide rare disease ecosystem. It is particularly valuable for patients, patient group leaders and caregivers who are considering starting a patient group or seeking to understand how patient groups can drive change.
Similarly, this course is valuable for other professionals such as healthcare providers, researchers, academics, and policymakers who want to gain a better understanding of how they can collaborate with patient groups.
Whether you’re looking to start a patient group, learn more about rare disease patient groups, advocate for better care or drive change through collaboration, this course offers a comprehensive introduction!
You may also be interested in…
Resource Content
What is a patient group?
What is a patient group?
You don't currently have access to this content
Why patient groups matter in rare diseases
Why patient groups matter in rare diseases
You don't currently have access to this content
Examples of patient groups in rare diseases
You don't currently have access to this content
What patient groups do
Support and empowerment
You don't currently have access to this content
Education and awareness
You don't currently have access to this content
Research and policy engagement
You don't currently have access to this content
The importance of collaboration
The importance of collaboration
You don't currently have access to this content
Collaborations among patient groups
Collaborations among patient groups
You don't currently have access to this content
Collaborations with other stakeholders
Healthcare professionals
You don't currently have access to this content
Academic Institutions/Researchers
You don't currently have access to this content
Pharmaceutical Industry
You don't currently have access to this content
Regulatory Agencies
You don't currently have access to this content
Funders, policymakers and reimbursement bodies
You don't currently have access to this content
Common challenges faced by patient groups and how to start navigating them
Common challenges faced by patient groups and how to start navigating them
You don't currently have access to this content
Resource constraints and sustainability
You don't currently have access to this content
Public awareness and visibility
You don't currently have access to this content
Providing professional patient and family support, while preserving own mental health
You don't currently have access to this content
Community and stakeholder engagement
You don't currently have access to this content
Summary and conclusion
Summary and conclusion
You don't currently have access to this content
Feedback
You don't currently have access to this content